Literature DB >> 17462462

Cervical thymectomy for intrathymic parathyroid adenomas during minimally invasive parathyroidectomy.

Peter Stalberg1, Simon Grodski, Stan Sidhu, Mark Sywak, Leigh Delbridge.   

Abstract

BACKGROUND: The development of an intrathymic parathyroid adenoma is common, and thymectomy is a significant component of the parathyroid surgeon's technical armamentarium. Over the last decade, minimally invasive parathyroidectomy (MIP) has become the standard technique for removal of an abnormal parathyroid gland, and the requirement for thymectomy should remain unchanged during the era of minimally invasive techniques. The aim of this paper was to assess the feasibility and outcomes of cervical thymectomy for intrathymic parathyroid adenomas during MIP.
METHODS: This is a retrospective case series. The study group comprised all patients undergoing parathyroidectomy in the University of Sydney Endocrine Surgical Unit during a 5-year period (January 2001 to December 2005). Patients undergoing MIP and open parathyroidectomy with a concomitant cervical thymectomy were compared.
RESULTS: A total of 840 patients underwent parathyroid surgery for primary hyperparathyroidism (PHPT) during this period. A total of 30 MIP procedures with concurrent thymectomy were performed, and 99 open bilateral neck explorations with cervical thymectomy were performed. Of the MIP thymectomy group, there were 25 female and 5 male patients; the average age was 57 years (range, 22 to 82). A mean length of 34 mm of thymus was extracted via the minimally invasive approach (range, 8 to 85 mm). In 5 cases, only fatty tissue was identified histologically, and, in 5 cases, a small supernumerary parathyroid gland was identified in the histologic specimen. Only 1 patient suffered temporary, recurrent laryngeal nerve palsy; there were no cases of postoperative hemorrhage requiring return to the operating room.
CONCLUSIONS: Cervical thymectomy for removal of intrathymic parathyroid adenomas can be performed during lateral focused mini-incision MIP with a safety and efficacy equivalent to open bilateral neck explorations.

Entities:  

Mesh:

Year:  2007        PMID: 17462462     DOI: 10.1016/j.surg.2006.11.010

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  6 in total

Review 1.  Outcomes of Parathyroidectomy in Patients with Primary Hyperparathyroidism: A Systematic Review and Meta-analysis.

Authors:  Naykky M Singh Ospina; Rene Rodriguez-Gutierrez; Spyridoula Maraka; Ana E Espinosa de Ycaza; Sina Jasim; Ana Castaneda-Guarderas; Michael R Gionfriddo; Alaa Al Nofal; Juan P Brito; Patricia Erwin; Melanie Richards; Robert Wermers; Victor M Montori
Journal:  World J Surg       Date:  2016-10       Impact factor: 3.352

Review 2.  Parathyroid Pathology.

Authors:  Julie Guilmette; Peter M Sadow
Journal:  Surg Pathol Clin       Date:  2019-09-27

3.  Intrathymic ectopic parathyroid adenoma caused primary hyperparathyroidism with vitamin D deficiency several years after bariatric surgery.

Authors:  Francesco Sellitri; Alessandro Tamburrini; Federico Tacconi; Patrizio Bollero; Andrea Ortensi; Tommaso Claudio Mineo
Journal:  Thorac Cancer       Date:  2015-01-07       Impact factor: 3.500

4.  Prevalence of Thymic Parathyroids in Primary Hyperparathyroidism During Radioguided Parathyroidectomy.

Authors:  Sophie Dream; Brenessa Lindeman; Herbert Chen
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2019-08-14

5.  Thoracoscopic approach in the treatment of ectopic thymic parathyroid adenoma.

Authors:  Virgilijus Beiša; Neringa Pranskevičiūtė; Gabija Makūnaitė; Kęstutis Strupas
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2018-02-07       Impact factor: 1.195

6.  The role of unhenanced CT in a ruptured parathyroid adenoma: A case report.

Authors:  Romilda Lombardi; Carmine Franco Muccio; Valeria D'Auria; Valerio D'Agostino; Stefano Genovese; Alessandro Monaci; Pasquale La Selva; Anna Castaldo; Ilaria Pesce; Alfonso Bencivenga
Journal:  Radiol Case Rep       Date:  2021-07-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.